Orthofix Medical Inc
F:OM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orthofix Medical Inc
F:OM2
|
US |
|
Rocky Mountain Chocolate Factory Inc (Delaware)
F:RMFA
|
US |
|
Suncorp Group Ltd
ASX:SUN
|
AU |
|
sino AG
F:XTP
|
DE |
|
G
|
Graham Holdings Co
SWB:WPOB
|
US |
|
Origin Energy Ltd
ASX:ORG
|
AU |
|
Tai Sin Electric Ltd
SGX:500
|
SG |
|
K
|
Krungthai Card PCL
SET:KTC
|
TH |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
D
|
Danaher Corp
F:DAP
|
US |
|
M
|
Madrigal Pharmaceuticals Inc
F:YDO1
|
US |
|
Amphastar Pharmaceuticals Inc
F:29A
|
US |
|
S
|
Southcorp Capital Inc
OTC:STHC
|
US |
Wall St Price Targets
OM2 Price Targets Summary
Orthofix Medical Inc
According to Wall Street analysts, the average 1-year price target for
OM2 is 18.49 EUR with a low forecast of 16.9 EUR and a high forecast of 20.5 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OM2's stock price target?
Price Target
18.49
EUR
According to Wall Street analysts, the average 1-year price target for
OM2 is 18.49 EUR with a low forecast of 16.9 EUR and a high forecast of 20.5 EUR.
What is the Revenue forecast for Orthofix Medical Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Orthofix Medical Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 7%.